An experimental trial of recombinant human interferon alpha nasal drops to prevent coronavirus disease 2019 in medical staff in an epidemic area

ObjectiveTo investigate the efficacy and safety of recombinant human interferon alpha (rhIFN-) nasal drops in healthy medical staff to prevent coronavirus disease 2019 (COVID-19). MethodsA prospective, open-label study was conducted in January 21, 2020at Taihe Hospital in Shiyan City, Hubei Province. Totally, 2944 medical staff members were recruited and allocated into... Show more